America’s oldest public hospital is stress-testing the health care system from the inside — before a real outbreak forces the issue.
Bellevue launched one of the more unconventional public health preparedness programs seen in recent years. Trained clinical evaluators, posing as ordinary patients, began walking unannounced into health care facilities across the region — presenting with symptoms and exposure histories that mirror what a real avian influenza case might look like. Nobody on the receiving end knows they are coming.
The program is called the Mystery Patient initiative, and its goal is straightforward: find out whether America’s health care facilities are actually ready for H5N1 before H5N1 arrives.
How the Program Works
As part of the program, trained clinical evaluators acting as patients present unannounced to participating facilities with symptoms and exposure histories consistent with avian flu. These exercises simulate real-world conditions and are designed to test a facility’s ability to rapidly identify, isolate, and inform appropriate infection control teams and public health authorities.
The drill is not a theoretical tabletop exercise. It unfolds in real time within active clinical settings, using the same waiting rooms, triage desks, and staff workflows that would handle a genuine patient. The evaluator arrives, presents a plausible clinical picture, and the clock starts. How quickly does the facility recognize a potential high-consequence case? Does staff reach for the correct personal protective equipment? Is the right public health authority notified in the right sequence?
The program evaluates critical components of infectious disease preparedness, including the speed and effectiveness of patient identification through screening and triage, implementation of infection control measures including masking and isolation, and adherence to appropriate personal protective equipment protocols.
Each drill runs for up to two hours, beginning the moment the simulated patient enters the facility and concluding at the point of initial evaluation and escalation. After each exercise, participating facilities receive a detailed After-Action Report and Improvement Plan, outlining strengths, identifying opportunities for improvement, and providing targeted recommendations. Facilities may also receive additional training and guidance to address identified gaps.
Crucially, the program is voluntary. Bellevue has framed it not as a compliance inspection but as a quality improvement tool — one designed to support frontline staff rather than penalize them for gaps discovered under pressure.
Why Bellevue, and Why Now
Bellevue Hospital is not a random participant in this effort. NYC Health + Hospitals/Bellevue is the designated Regional Emerging Special Pathogen Treatment Center for HHS Region 2, leading special pathogen preparedness and response efforts in New York, New Jersey, Puerto Rico, and the U.S. Virgin Islands.
That designation carries real weight. Bellevue was one of only three institutions in the United States to treat patients during the 2014 Ebola outbreak and subsequently helped establish the National Emerging Special Pathogens Training and Education Center — the national consortium built to share preparedness expertise across health systems. When Bellevue develops a program like this, it is doing so from a position of hard-won institutional knowledge about what gaps look like in a genuine outbreak response.
The timing of the launch is also deliberate. H5N1, the highly pathogenic strain of avian influenza, has remained a source of concern for public health officials throughout 2025 and into 2026. While the risk to the general public remains low, the virus carries a historically high fatality rate among those infected, and the concern among epidemiologists has long been less about current case counts and more about preparedness lag — the gap between when a novel pathogen begins spreading and when health systems are genuinely ready to receive it.
Vikramjit Mukherjee, MD, Chief of Critical Care and Chief of the Special Pathogens Program at Bellevue, said: “Partnership and preparedness are central to all of the work that we do. By working alongside facilities that choose to participate, we are helping ensure that when a high-risk patient presents, teams are ready to respond quickly, safely, and effectively.”
The Gap Between Protocol and Practice
The Mystery Patient program addresses something that public health preparedness planning has historically struggled to measure: the difference between having a written protocol and actually executing it under pressure, with real staff and real workflows.
Health care facilities across the country maintain infection control policies for high-consequence infectious diseases. They conduct training sessions. They update procedures after guidance from the Centers for Disease Control and Prevention. But the moment of truth — when an unfamiliar presentation walks through the front door and the protocol has to translate into immediate action — is something that only a live drill can replicate.
Andrew Wallach, MD, Chief of Ambulatory Care and Special Pathogens Program Steering Committee Member, said: “This program reflects the kind of proactive, real-world readiness we strive for across all care settings. By giving facilities the opportunity to test their protocols in a safe and supportive way, we can strengthen frontline response, reinforce best practices, and ultimately improve patient and staff safety.”
The program’s non-punitive design is intentional. Identifying a gap during a drill is exactly the outcome Bellevue is seeking — far better than discovering the same gap when a real patient presents with confirmed H5N1 exposure.
National Relevance Heading Into Summer
The launch of the Mystery Patient program comes as federal and state health agencies are increasingly treating H5N1 preparedness as an active priority rather than a distant contingency. Bellevue itself received $2 million in federal funding from the U.S. Department of Health and Human Services to enhance national avian influenza preparedness, making it one of only thirteen institutions nationwide selected for that investment.
For the broader American health care system, the initiative offers a model worth watching. The question of whether hospitals, urgent care centers, and community health facilities can correctly identify and isolate a high-consequence infectious disease patient — in the first minutes, before confirmation, under routine staffing conditions — is not a niche concern. It is the foundational question of outbreak preparedness.
What Bellevue is testing in New York is whether the system works when it has to, not just when it is being evaluated on paper. The answer to that question matters well beyond the borders of HHS Region 2.
